Page last updated: 2024-10-29

isoniazid and Rheumatism

isoniazid has been researched along with Rheumatism in 25 studies

Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).

Research Excerpts

ExcerptRelevanceReference
"In this study, we investigated the safety and toxicity of isoniazid (INH) intervention therapy to the patients with latent tuberculosis who were given tumor necrosis factor alpha (TNFalpha) for the treatment of their rheumatologic diseases."9.12Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. ( Hanta, I; Kocabas, A; Kuleci, S; Ozbek, S; Sert, M, 2007)
"To investigate the incidence of tuberculosis (TB) in patients with rheumatic diseases receiving high-dose glucocorticoids and to evaluate the preventive effect of isoniazid (INH)."7.96Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids. ( Curtis, JR; Lee, EB; Lee, H; Lee, JK; Park, JW; Song, YW, 2020)
"In this study, we investigated the safety and toxicity of isoniazid (INH) intervention therapy to the patients with latent tuberculosis who were given tumor necrosis factor alpha (TNFalpha) for the treatment of their rheumatologic diseases."5.12Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. ( Hanta, I; Kocabas, A; Kuleci, S; Ozbek, S; Sert, M, 2007)
"To investigate the incidence of tuberculosis (TB) in patients with rheumatic diseases receiving high-dose glucocorticoids and to evaluate the preventive effect of isoniazid (INH)."3.96Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids. ( Curtis, JR; Lee, EB; Lee, H; Lee, JK; Park, JW; Song, YW, 2020)
" For treatment of latent tuberculosis infection (LTBI) overall, 49% of the respondents would refer management to infectious disease specialist or the health department, 37% would initiate isoniazid for 9 or 12 months, and 14% would use isoniazid for 6 months."3.85Screening and Treatment of Latent Tuberculosis Among Patients Receiving Biologic Agents: A National and International Survey of Rheumatologists. ( Carbone, L; Garcia-Rosell, M; Pattanaik, D; Raza, SH; Tran, NQ, 2017)
" Steroid dosage varied according to diagnosis and severity."2.69Is a purified protein derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids? ( Andonopoulos, AP; Bounas, A; Karokis, D; Safridi, C, 1998)
"Isoniazid was prescribed if any one test was positive."1.56Comparison of single and dual latent tuberculosis screening strategies before biologic and targeted therapy in patients with rheumatic diseases: a retrospective cohort study. ( Lao, V; Luk, L; Pang, S; So, H; Tang, I; Wong, V; Yip, R, 2020)
"Data from regular monitoring for latent tuberculosis infection [LTBI] during biologic treatment are lacking."1.48A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases. ( Chen, M; Hung, E; Ip, M; Lee, CK; Lui, G; Ng, SC; Tam, LS; Tang, W; Wong, SHV; Wu, JC, 2018)
" Although the use of INH therapy in combination with DMARDs and/or biologics was generally well tolerated, the rate of LFT abnormalities was higher when patients were exposed to INH, and significant abnormalities were more frequent than reported in the INH literature."1.40Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents. ( Arino-Torregrosa, M; Bourré-Tessier, J; Choquette, D, 2014)

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19909 (36.00)18.7374
1990's1 (4.00)18.2507
2000's3 (12.00)29.6817
2010's10 (40.00)24.3611
2020's2 (8.00)2.80

Authors

AuthorsStudies
Tang, I1
So, H1
Luk, L1
Wong, V1
Pang, S1
Lao, V1
Yip, R1
Park, JW1
Curtis, JR1
Lee, H1
Lee, JK1
Song, YW1
Lee, EB1
Lee, CK1
Wong, SHV1
Lui, G1
Tang, W1
Tam, LS1
Ip, M1
Hung, E1
Chen, M1
Wu, JC1
Ng, SC1
He, D1
Bai, F1
Zhang, S1
Jiang, T1
Shen, J1
Zhu, Q1
Yue, T1
Shao, L1
Gao, Y1
Feng, Y1
Weng, X1
Zou, H1
Zhang, Y1
Zhang, W1
Kurt, OK1
Kurt, B1
Talay, F1
Tug, T1
Soy, M1
Bes, C1
Hayran, M1
Valls, V1
Ena, J1
Bourré-Tessier, J1
Arino-Torregrosa, M1
Choquette, D1
Atikan, BY1
Cavusoglu, C1
Dortkardesler, M1
Sozeri, B1
Tran, NQ1
Garcia-Rosell, M1
Pattanaik, D1
Raza, SH1
Carbone, L1
Ekochin, LH1
Manadan, AM1
Aggarwal, R1
Sequeira, W1
Block, JA1
Bray, MG1
Poulain, C1
Dougados, M1
Gossec, L1
Haroon, M1
Martin, U1
Devlin, J1
Nobre, CA1
Callado, MR1
Lima, JR1
Gomes, KW1
Martiniano, GV1
Vieira, WP1
WALCZAK, H1
Hanta, I1
Ozbek, S1
Kuleci, S1
Sert, M1
Kocabas, A1
Falagas, ME1
Voidonikola, PT1
Angelousi, AG1
Andonopoulos, AP1
Safridi, C1
Karokis, D1
Bounas, A1
Duroux, P1
Banerjee, HK1
Goldman, AL1
Braman, SS1
Anastasatu, C2
Stoia, I1
Kaufman, S1
Ghenoiu, O1
Iancovici, O2
Thibault, H1
Ritzel, R1
Vetter, GW1
Kauffmann, S1
Good, AE1

Reviews

1 review available for isoniazid and Rheumatism

ArticleYear
Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:6

    Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Cohort Studies; Female; Humans; Incidence;

2007

Trials

3 trials available for isoniazid and Rheumatism

ArticleYear
Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy.
    Clinical rheumatology, 2015, Volume: 34, Issue:1

    Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Humans;

2015
Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha.
    Clinical rheumatology, 2007, Volume: 26, Issue:11

    Topics: Adult; Alanine Transaminase; Antitubercular Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asp

2007
Is a purified protein derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids?
    Clinical rheumatology, 1998, Volume: 17, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Confidence Intervals

1998

Other Studies

21 other studies available for isoniazid and Rheumatism

ArticleYear
Comparison of single and dual latent tuberculosis screening strategies before biologic and targeted therapy in patients with rheumatic diseases: a retrospective cohort study.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2020, Volume: 26, Issue:2

    Topics: Adult; Aged; Biological Products; Female; Humans; Incidence; Infliximab; Interferon-gamma Release Te

2020
Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Adult; Antitubercular Agents; Female; Glucocorticoids; Humans; Isoniazid; Male; Middle Aged; Prognos

2020
A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases.
    Journal of Crohn's & colitis, 2018, Jul-30, Volume: 12, Issue:8

    Topics: Adult; Antirheumatic Agents; Antitubercular Agents; Biological Therapy; Female; Gastrointestinal Age

2018
High incidence of tuberculosis infection in rheumatic diseases and impact for chemoprophylactic prevention of tuberculosis activation during biologics therapy.
    Clinical and vaccine immunology : CVI, 2013, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Biological Products; Chemoprevention; Female; Humans

2013
Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis.
    Wiener klinische Wochenschrift, 2013, Volume: 125, Issue:19-20

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Chemoprevention; Drug-Related

2013
Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents.
    Clinical rheumatology, 2014, Volume: 33, Issue:8

    Topics: Adult; Antirheumatic Agents; Antitubercular Agents; Biological Products; Chemical and Drug Induced L

2014
Assessment of tuberculosis infection during treatment with biologic agents in a BCG-vaccinated pediatric population.
    Clinical rheumatology, 2016, Volume: 35, Issue:2

    Topics: Adolescent; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Female; Follow-Up Studies;

2016
Screening and Treatment of Latent Tuberculosis Among Patients Receiving Biologic Agents: A National and International Survey of Rheumatologists.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:1

    Topics: Antitubercular Agents; Attitude of Health Personnel; Biological Products; Female; Humans; Interferon

2017
Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
    The Journal of rheumatology, 2009, Volume: 36, Issue:9

    Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid;

2009
Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment.
    Joint bone spine, 2010, Volume: 77, Issue:2

    Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Female; Hu

2010
High incidence of intolerance to tuberculosis chemoprophylaxis.
    Rheumatology international, 2012, Volume: 32, Issue:1

    Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ch

2012
Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.
    Rheumatology international, 2012, Volume: 32, Issue:9

    Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Antitubercular Agents; Arthritis, Psoriatic; Ar

2012
[ON THE TREATMENT OF DIFFERENT TYPES OF RHEUMATIC DISEASES IN PULMONARY TUBERCULOSIS AND LUNG TUMORS].
    Zeitschrift fur Tuberkulose und Erkrankungen der Thoraxorgane, 1964, Volume: 121

    Topics: Agranulocytosis; Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Leukopenia; Lung; Lung Neopla

1964
[Surveillance and complications of antituberculosis chemotherapy].
    La Revue du praticien, 1979, Jun-11, Volume: 29, Issue:33

    Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity

1979
Rheumatoid syndrome during antitubercular therapy.
    The Journal of the Association of Physicians of India, 1977, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Pyridoxine; Rheumatic Diseases

1977
Isoniazid: a review with emphasis on adverse effects.
    Chest, 1972, Volume: 62, Issue:1

    Topics: Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Desensitization, Immunologic; Drug Hypers

1972
[Rheumatic diseases caused by antitubercular drugs].
    Zeitschrift fur Erkrankungen der Atmungsorgane mit Folia bronchologica, 1972, Volume: 136, Issue:1

    Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Arthritis, Rheumatoid; Cycloserine; Dupuyt

1972
[Uncommon reactions to isoniazid].
    La Nouvelle presse medicale, 1973, Jan-06, Volume: 2, Issue:1

    Topics: Central Nervous System; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Interact

1973
[Experience with Delta-Tomanol, a new antirheumatic combination preparation].
    Deutsches medizinisches Journal, 1968, Nov-20, Volume: 19, Issue:22

    Topics: Drug Synergism; Humans; Isoniazid; Phenylbutazone; Prednisolone; Rheumatic Diseases

1968
[Manifestations of a rheumatic type caused by antituberculosis chemotherapy].
    Medicina interna, 1969, Volume: 21, Issue:5

    Topics: Acrodynia; Aged; Antitubercular Agents; Arthritis, Rheumatoid; Cycloserine; Ethionamide; Female; Hum

1969
Rheumatism and chemotherapy of tuberculosis.
    Annals of internal medicine, 1970, Volume: 72, Issue:5

    Topics: Humans; Isoniazid; Rheumatic Diseases; Tuberculosis

1970